Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Cheung

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Urology|June 12, 2016
Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older MenChristopher J D Wallis, Alyson L Mahar, Patrick Cheung, et al.
European Urology|November 18, 2015
New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older MenChristopher J D Wallis, Alyson Mahar, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2025
Bowel bag dosimetric parameters for ultrahypofractionated pelvic elective nodal irradiation in prostate cancerWee Loon Ong, Melanie Davidson, Matt Wronski, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Nano Letters|February 6, 2019
Determining Interaction Enhanced Valley Susceptibility in Spin-Valley-Locked MoS<sub>2</sub>Jiangxiazi Lin, Tianyi Han, Benjamin A Piot, et al.
Neurosurgery|March 28, 2022
Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local ControlAhmed Abugharib, K Liang Zeng, Chia-Lin Tseng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate CancerHima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2023
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastasesEric K Nguyen, Renee Korol, Saher Ali, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Urology|June 12, 2016
Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older MenChristopher J D Wallis, Alyson L Mahar, Patrick Cheung, et al.
European Urology|November 18, 2015
New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older MenChristopher J D Wallis, Alyson Mahar, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2025
Bowel bag dosimetric parameters for ultrahypofractionated pelvic elective nodal irradiation in prostate cancerWee Loon Ong, Melanie Davidson, Matt Wronski, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Nano Letters|February 6, 2019
Determining Interaction Enhanced Valley Susceptibility in Spin-Valley-Locked MoS<sub>2</sub>Jiangxiazi Lin, Tianyi Han, Benjamin A Piot, et al.
Neurosurgery|March 28, 2022
Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local ControlAhmed Abugharib, K Liang Zeng, Chia-Lin Tseng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate CancerHima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2023
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastasesEric K Nguyen, Renee Korol, Saher Ali, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Pageof 15